The Technetium-99m market is thriving, with development potential driven by changing healthcare demands and technology advancements. There is significant potential for the use of Technetium-99m in the treatment of an expanding variety of chronic and noncommunicable diseases, particularly in clinical studies such as scans that increase diagnosis procedures.
Governments are implementing health programs to increase diagnostic imaging and treatment options.
Rise in demand for advanced nuclear imaging infrastructure for illness detection and treatment fuels the Technetium-99m market size; SPECT detector technology is evolving with a wider range of applications in preclinical research as well as improved diagnostic accuracy.
The Technetium-99m industry presents lucrative opportunities for strong growth, enabling stakeholders to take advantage of current trends and innovations as medicine moves toward early disease detection and precise imaging techniques.
Technetium-99m is an important isotope used in nuclear medicine, serving as the foundation for all diagnostic imaging operations around the world. From urinary tract imaging to heart scanning, health practitioners rely heavily on it to detect and treat disorders.
A growing need exists for advanced nuclear imaging infrastructure in illness detection and therapy that serves the healthcare industry; SPECT detector technology is expanding its horizons with a broader variety of applications in preclinical research as well as improved diagnostic precision.
Technetium-99m market growth is highly positive, allowing players to cash in on emerging trends and innovations since medicine continues heading into early disease detection and precise imaging methods.
Expansion of health infrastructure, rise in healthcare expenditure, and worldwide health initiatives emphasizing inventive medical technologies are key factors bolstering Technetium-99m market demand.
In this regard, as healthcare providers and researchers become more aware of the role and benefits that Technetium-99m can play in improving patient outcomes and treatment efficiency, all stakeholders seeking to capitalize on this critical radiopharmaceutical's expanding use and demand chain are likely to find numerous Technetium-99m market opportunities.
| Attribute | Detail |
|---|---|
| Drivers |
|
The COVID-19 pandemic highlighted the importance of increasing investment in global Human Resources for Health (HRH), implying that such expenditure should be enhanced.
Workforce 2030, the WHO Global Strategy on HRH, estimates an 18-million shortage of health professionals by 2030, with the gap worsening in low- and lower-middle-income countries. In exchange, HRH offers investments that will improve population health while also stimulating economic growth through employment creation.
To enhance human resource health (HRH), India has set up a National Medical Commission and offered 1.5 million jobs with respect to other public sector healthcare sectors. The increasing need for contemporary medical infrastructure is driving up demand for Technetium-99m, a key radioisotope for urinary tract imaging.
The burden of noncommunicable diseases (NCDs) is rapidly increasing, particularly in low- and middle-income countries, with over 40 million deaths per year.
An increasing number of non-communicable diseases (NCDs) such as cardiovascular diseases (CVD), cancer, and Alzheimer’s disease are influencing the requirement for medical apparatuses and diagnosis devices used for therapy.
Early diagnosis and therapy requires nuclear imaging methods such as single-photon emission computed tomography (SPECT), positron emission tomography (PET), or computed tomography (CT).
Consequently, improvements in healthcare facilities and growth in expenditures in the healthcare sector and international health initiatives drives 99mTc-based nuclear imaging, consequently boosting the Technetium-99m market value.
The Technetium-99m market segmentation based on clinical services includes bone scan, renal scan, cardiac scan, and neurology scan. The market for cardiac scans is predicted to grow at a rapid CAGR throughout the forecast period.
CT hardware advances, such as faster gantry rotation speeds, more detector coverage, and improved spatial resolution, allow for imaging of the beating heart.
GE Healthcare can obtain a picture during single heartbeat with a CT scanner that rotates at 0.23 seconds and has a coverage of 160mm. Thus, the use of beta-blockers may not be necessary at all.
State-of-the-art, ultra-high-resolution scanners that use photon-counting computed tomography provides great image quality and precise identification of coronary artery disease in high-risk patients, enlarging the group that can benefit from noninvasive cardiac imaging.
Improvements in cardiac CT software in terms of overall improvement have been realized through various means such as non-invasive FFR assessment, characterization of coronary plaque, and analysis of fat tissues. Furthermore, AI can help make processes more efficient, improve image quality, as well as lower the volume of contrast media used.
Demand for cardiac CT imaging rises as healthcare professionals recognize its value in the identification, characterisation, and stratification of coronary artery disease. This increasing adoption rate is driving market progress.
As per the Technetium-99m market report, the single photon emission computed tomography (SPECT) segment is expected to expand at a fast pace in the technetium market based on isotopic application.
The advent of more sensitive and higher spatial resolution detectors such as Cadmium-Zinc-Telluride detectors has made it possible to have shorter acquisition times and better energy resolution for SPECT imaging.
SPECT/CT has improved diagnostic accuracy, allowing for better disease localization and characterisation. Advanced image processing methods have also led to enhanced image quality for SPECT scans, allowing for faster acquisition times without sacrificing diagnostic accuracy.
Small-animal SPECT systems broaden the uses of this technology in preclinical studies. These are the elements driving rapid Technetium-99m market share of the SPECT scan segment.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the Technetium-99m market analysis, North America dominates the landscape. Government authorities such as the US FDA and NRC establish safety standards for the use of Technetium in medical applications.
These laws govern safe handling and optimal use in order to sustain the Technetium market. Various North America government programs and grants provide funding for development and research efforts in health care and biotechnology.
The NIH and DOE frequently sponsor radiopharmaceutical research programs that incorporate Technetium research. Governmental-private partnerships and cooperation encourage innovation within governmental institutions and commercial firms. Such cooperation result in technological advancements and applications for Technetium production.
The market is highly competitive and has a strong presence of key players. The Technetium-99m market report highlights that leading players are adopting strategies such as acquisition and launch of new products.
Advanced Accelerator Applications S.A., Advanced Cyclotron Systems, Inc., Bayer AG, GE Healthcare, Philips Healthcare (Koninklijke Philips N.V.), Siemens Healthineers, Eckert & Ziegler, IBA Radiopharma Solutions, Medi-Radiopharma Kft., Lantheus Holdings, Inc., Nordion, Inc., Sumitomo Heavy Industries, Ltd., NTP Radioisotopes SOC Ltd, Isotope JSC., China lsotope & Radiation Corporation, SDS Lifesciences Pvt. Ltd., Jubilant Life Sciences, and BWX Technologies, Inc. are the prominent Technetium-99m market manufacturers.
Key players have been profiled in the Technetium-99m market research report, based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2023 | US$ 6.0 Bn |
| Forecast (Value) in 2034 | US$ 8.6 Bn |
| Growth Rate (CAGR) | 3.3% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Technetium-99 market to surpass the value of ~US$ 4 Bn by the end of 2030
Technetium-99m market is projected to expand at a CAGR of 3.5% from 2020 to 2030
Technetium-99 market is driven by rise in nuclear imaging and healthcare infrastructure and increase in per-capita healthcare expenditure
Asia Pacific accounted for a major share of the global technetium-99 market
Key players in the global Technetium-99m market include GE Healthcare, Curium, Lantheus Medical Imaging, Inc., Mallinckrodt, Siemens Healthineers
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Technetium-99m Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Technetium-99m Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Porters Five Forces Analysis
5.3. PESTEL Analysis
5.4. Health Care Industry Overview
5.5. SPECT Scanner/Gamma Camera by Continent
5.6. Mo-99 Producers and Production Capacity
5.7. Installed Base Scenario (2021)
5.8. FDA Approved Technitium-99m Based Radiopharmaceuticals Products
5.9. Regulatory Scenarios, By Region
5.10. Cost Analysis of Cyclotrons facility
5.11. Cyclotron and Radiopharmaceutical Facilities
5.12. Supply Chain Analysis
6. Global Technetium-99m Market Analysis and Forecast, By Clinical Services
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Clinical Services, 2020-2034
6.3.1. Bone scan
6.3.2. Renal Scan
6.3.3. Cardiac Scan
6.3.4. Neurology Scan
6.4. Market Attractiveness By Clinical Services
7. Global Technetium-99m Market Analysis and Forecast, By Isotopic Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Isotopic Application, 2020-2034
7.3.1. Gamma Camera
7.3.2. Single Photon Emission Computed Tomography (SPECT)
7.4. Market Attractiveness By Isotopic Application
8. Global Technetium-99m Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Technetium-99m Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Technetium-99m Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Clinical Services, 2020-2034
10.2.1. Bone scan
10.2.2. Renal Scan
10.2.3. Cardiac Scan
10.2.4. Neurology Scan
10.3. Market Value Forecast By Isotopic Application, 2020-2034
10.3.1. Gamma Camera
10.3.2. Single Photon Emission Computed Tomography (SPECT)
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Diagnostic Centers
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Clinical Services
10.6.2. By Isotopic Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Technetium-99m Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Clinical Services, 2020-2034
11.2.1. Bone scan
11.2.2. Renal Scan
11.2.3. Cardiac Scan
11.2.4. Neurology Scan
11.3. Market Value Forecast By Isotopic Application, 2020-2034
11.3.1. Gamma Camera
11.3.2. Single Photon Emission Computed Tomography (SPECT)
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Diagnostic Centers
11.4.3. Others
11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Clinical Services
11.6.2. By Isotopic Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Technetium-99m Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Clinical Services, 2020-2034
12.2.1. Bone scan
12.2.2. Renal Scan
12.2.3. Cardiac Scan
12.2.4. Neurology Scan
12.3. Market Value Forecast By Isotopic Application, 2020-2034
12.3.1. Gamma Camera
12.3.2. Single Photon Emission Computed Tomography (SPECT)
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Diagnostic Centers
12.4.3. Others
12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Clinical Services
12.6.2. By Isotopic Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Technetium-99m Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Clinical Services, 2020-2034
13.2.1. Bone scan
13.2.2. Renal Scan
13.2.3. Cardiac Scan
13.2.4. Neurology Scan
13.3. Market Value Forecast By Isotopic Application, 2020-2034
13.3.1. Gamma Camera
13.3.2. Single Photon Emission Computed Tomography (SPECT)
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Diagnostic Centers
13.4.3. Others
13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Clinical Services
13.6.2. By Isotopic Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Technetium-99m Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Clinical Services, 2020-2034
14.2.1. Bone scan
14.2.2. Renal Scan
14.2.3. Cardiac Scan
14.2.4. Neurology Scan
14.3. Market Value Forecast By Isotopic Application, 2020-2034
14.3.1. Gamma Camera
14.3.2. Single Photon Emission Computed Tomography (SPECT)
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Diagnostic Centers
14.4.3. Others
14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Clinical Services
14.6.2. By Isotopic Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Advanced Accelerator Applications S.A.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Advanced Cyclotron Systems, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Bayer AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Eckert & Ziegler
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. GE Healthcare
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. IBA Radiopharma Solutions
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Jubilant Life Sciences
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Lantheus Holdings, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Nordion, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Medi-Radiopharma Kft.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 02: Global Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 03: Global Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Technetium-99m Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Technetium-99m Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 07: North America Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 08: North America Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Technetium-99m Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 11: Europe Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 12: Europe Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Technetium-99m Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 15: Asia Pacific Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 16: Asia Pacific Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Technetium-99m Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 19: Latin America Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 20: Latin America Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Technetium-99m Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Technetium-99m Market Value (US$ Mn) Forecast, by Clinical Services, 2020-2034
Table 23: Middle East & Africa Technetium-99m Market Value (US$ Mn) Forecast, by Isotopic Application, 2020-2034
Table 24: Middle East & Africa Technetium-99m Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Technetium-99m Market Size, by Clinical Services, 2023
Figure 02: Technetium-99m Market share (%), by Clinical Services, 2023
Figure 03: Technetium-99m Market Size, by Isotopic Application, 2023
Figure 04: Technetium-99m Market share (%), by Isotopic Application, 2023
Figure 05: Technetium-99m Market Size, by End-user, 2023
Figure 06: Technetium-99m Market share (%), by End-user, 2023
Figure 07: Global Technetium-99m Market, By Region (2023 and 2034)
Figure 08: Global Technetium-99m Market Value (US$ Mn) Forecast, 2020-2034
Figure 09: Global Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 10: Global Technetium-99m Market Value Share Analysis, by Clinical Services, 2023
Figure 11: Global Technetium-99m Market Value Share Analysis, by Clinical Services, 2034
Figure 12: Global Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 13: Global Technetium-99m Market Value (US$ Mn), by Bone scan, 2020‒2034
Figure 14: Global Technetium-99m Market Value Share Analysis, by Bone scan, 2023 and 2034
Figure 15: Global Technetium-99m Market Value (US$ Mn), by Renal scan, 2020‒2034
Figure 16: Global Technetium-99m Market Value Share Analysis, Renal scan, 2023 and 2034
Figure 17: Global Technetium-99m Market Value (US$ Mn), by Cardiac scan, 2020‒2034
Figure 18: Global Technetium-99m Market Value Share Analysis, by Cardiac scan, 2023 and 2034
Figure 19: Global Technetium-99m Market Value (US$ Mn), by Neurology scan, 2020‒2034
Figure 20: Global Technetium-99m Market Value Share Analysis, by Neurology scan, 2023 and 2034
Figure 21: Global Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 22: Global Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023
Figure 23: Global Technetium-99m Market Value Share Analysis, by Isotopic Application, 2034
Figure 24: Global Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 25: Global Technetium-99m Market Value (US$ Mn), by Gamma Camera (ASO), 2020‒2034
Figure 26: Global Technetium-99m Market Value Share Analysis, by Gamma Camera, 2023 and 2034
Figure 27: Global Technetium-99m Market Value (US$ Mn), by Single Photon Emission Computed Tomography (SPECT), 2020‒2034
Figure 28: Global Technetium-99m Market Value Share Analysis, Single Photon Emission Computed Tomography (SPECT), 2023 and 2034
Figure 29: Global Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 30: Global Technetium-99m Market Value Share Analysis, by End-user, 2023
Figure 31: Global Technetium-99m Market Value Share Analysis, by End-user, 2034
Figure 32: Global Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Global Technetium-99m Market Value (US$ Mn), by Hospitals, 2020‒2034
Figure 34: Global Technetium-99m Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 35: Global Technetium-99m Market Value (US$ Mn), by Diagnostic Centers , 2020‒2034
Figure 36: Global Technetium-99m Market Value Share Analysis, Diagnostic Centers , 2023 and 2034
Figure 37: Global Technetium-99m Market Value (US$ Mn), by Others , 2020‒2034
Figure 38: Global Technetium-99m Market Value Share Analysis, by Others , 2023 and 2034
Figure 39: Global Technetium-99m Market Value Share Analysis, by Region, 2023 and 2034
Figure 40: Global Technetium-99m Market Attractiveness Analysis, by Region, 2024-2034
Figure 41: North America Technetium-99m Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 42: North America Technetium-99m Market Value Share Analysis, by Country, 2023 and 2034
Figure 43: North America Technetium-99m Market Attractiveness Analysis, by Country, 2024-2034
Figure 44: North America Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 45: North America Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 46: North America Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 47: North America Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 48: North America Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 49: North America Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Figure 50: Europe Technetium-99m Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 51: Europe Technetium-99m Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 52: Europe Technetium-99m Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 53: Europe Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 54: Europe Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 55: Europe Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 56: Europe Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 57: Europe Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 58: Europe Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Figure 59: Asia Pacific Technetium-99m Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 60: Asia Pacific Technetium-99m Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 61: Asia Pacific Technetium-99m Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 62: Asia Pacific Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 63: Asia Pacific Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 64: Asia Pacific Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 65: Asia Pacific Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 66: Asia Pacific Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 67: Asia Pacific Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Figure 68: Latin America Technetium-99m Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 69: Latin America Technetium-99m Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 70: Latin America Technetium-99m Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 71: Latin America Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 72: Latin America Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 73: Latin America Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 74: Latin America Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 75: Latin America Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 76: Latin America Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Figure 77: Middle East & Africa Technetium-99m Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 78: Middle East & Africa Technetium-99m Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 79: Middle East & Africa Technetium-99m Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 80: Middle East & Africa Technetium-99m Market Value Share Analysis, by Clinical Services, 2023 and 2034
Figure 81: Middle East & Africa Technetium-99m Market Attractiveness Analysis, by Clinical Services, 2024-2034
Figure 82: Middle East & Africa Technetium-99m Market Value Share Analysis, by Isotopic Application, 2023 and 2034
Figure 83: Middle East & Africa Technetium-99m Market Attractiveness Analysis, by Isotopic Application, 2024-2034
Figure 84: Middle East & Africa Technetium-99m Market Value Share Analysis, by End-user, 2023 and 2034
Figure 85: Middle East & Africa Technetium-99m Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Technetium-99m Market
